Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 4Phase 1 4Phase 4 3Phase 1/2 1

Status

Unknown 4

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1

Conditions

Liver, Cancer of, Primary Resectable 1Hepatocellular Carcinoma Resectable 1Head and Neck Squamous Cell Cancer 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × raltitrexed × Clear all
NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Zhujiang Hospital

Phase 3 Unknown
90 enrolled
Gastrointestinal

Hepatocellular Carcinoma Resectable

NCT05701436 2023-03-02

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Zhujiang Hospital

Phase 3 Unknown
144 enrolled

Liver, Cancer of, Primary Resectable

NCT05231382 2022-05-24

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

Sun Yat-sen University

Phase 3 Unknown
426 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02485548 2015-06-30

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

Jiangsu Cancer Institute & Hospital

Phase 3 Unknown
120 enrolled
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡